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We recently demonstrated that the adrenal cortices attached to aldosterone-producing 
adenoma (APA) contained microscopic subcapsular micronodules suggestive of active 
aldosterone production. In this study, we used in situ hybridization to investigate the 
mRNA expression of steroidogenic enzymes in the adrenal cortices attached to 
cortisol-producing adenoma (CPA) and clinically silent adenoma (nonfunctioning 
adenoma; NFA), in addition to APA. Microscopic subcapsular micronodules, which 
were several to hundreds of micrometers in size and spheroid in shape, were observed in 
the cortices attached to CPA and NFA, as well as APA, at high frequency. Most of the 
cortical nodules in zona fasciculata to zona reticularis showed a suppressed 
steroidogenesis in the cortices attached to adenoma, but some expressed intensely all 
necessary steroidogenic enzyme mRNAs for cortisol synthesis. It is thus necessary to 
keep in mind, on the occasion of subtotal adrenalectomy, that lesions with the potential 
to later develop into functional adrenocortical nodules may be present in other parts of 
the ipsilateral or contralateral adrenal cortices. (162 words) 
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Hyperfunction of the adrenal cortex is associated with either hyperplasia, adenoma, 
or carcinoma. There are principally three forms of adrenocortical hyperfunction, namely 
primary aldosteronism (PA), Cushing’s syndrome (CS) and congenital adrenal 
hyperplasia. PA and CS are thought to occur as quite distinct entities. Recently, case 
reports of adrenocortical adenoma overproducing both aldosterone and cortisol are 
becoming more frequent (1, 2), probably as the result of improvements in examination 
accuracy. Multiple or bilateral adrenocortical adenomas causing both PA and CS at the 
same time or at different periods have also been reported (3 - 5). These findings suggest 
that the same or a similar pathological condition may exist in the pathogenic 
background of adrenocortical adenomas, regardless of the type of hormone produced in 
excess. 
In aldosterone-producing adenoma (APA), the remaining adrenal cortices often show 
hyperplasia of the zona glomerulosa (ZG), and one or more micro- or macronodules. 
Unlike the cortices adhering to APA, the remaining cortices in cortisol-producing 
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adenoma (CPA) invariably appear atrophic, but cortical nodules with a diffuse brown or 
yellow colour can also be seen occasionally, especially in cases of ACTH-independent 
bilateral or multiple adrenocortical adenomas (6, 7). Most of the cortical nodules in the 
cortices attached to functional adrenocortical adenomas have been thought to be 
incidental and nonfunctional, probably related to vascular sclerosis (8). However, 
histochemical and electron microscopic studies have shown that some ischemia-related 
cortical nodules had steroidogenic activity (9, 10). We recently demonstrated that the 
cortices attached to APA contained not only microscopic subcapsular micronodules 
suggesting active aldosterone production, as observed in BAH and UAH, but also 
cortical nodules suggesting the capability for producing cortisol (11). Hence, the 
possibility is suggested that buds with autonomous production of aldosterone or cortisol 
may exist in the cortices attached to APA. 
Laparoscopically subtotal adrenalectomy with preservation of functional adrenal 
tissue has been attempted (12, 13). This approach would seem to be successful, although 
the postoperative long-term follow-up is often inadequate (5, 7, 14). Meanwhile, the 
recurrence of PA or CS following total or subtotal adrenalectomy has been also reported 
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(3, 15 – 17). Therefore, knowledge about what lesions are present in the remaining 
cortices is essential. In this study, we used in situ hybridization to examine the 
expression of mRNAs for steroidogenic enzymes in the remaining adrenal cortices 
attached to adrenocortical adenomas associated with PA and CS, as well as in clinically 
silent cases (NF). 
 




Of the paraffin-embedded human adrenal tissues listed in the Division of Pathology, 
Nagasaki University Graduate School of Biomedical Sciences, and Red-Cross Nagasaki 
Atomic Bomb Hospital between 1988 and 2006, 19 cases of CP and 11 of NF were 
identified (Table 1). Seven cases of PA operated on between 2005 and 2006 were also 
selected (Table 1). As controls, we used five adrenal glands obtained from patients 
undergoing adrenalectomy together with pancreatectomy or nephrectomy for pancreatic 
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or renal cancer, who did not reveal any endocrine abnormalities. PA was diagnosed on 
the basis of an elevated plasma-aldosterone concentration and suppressed plasma-renin 
activity or concentration. The diagnosis of CS was based on symptoms such as obesity, 
moon face, buffalo hump, abdominal striae etc., elevated plasma-cortisol concentration 
with lack of diurnal rhythm, and suppressed plasma ACTH level. The exact location of 
the lesions in all cases of PA and CS was determined by adrenal venous sampling (AVS). 
Clinically silent adenoma (NFA), showing normal-range plasma aldosterone and 
cortisol concentrations, was incidentally detected by CT scan. However, cases 30, 32, 
34, 36 and 37 showed low levels of plasma ACTH, loss of circadian rhythm, or isotope 
accumulation on an I131-adosterol scintigram (Table 1). As shown in Table 2, all adrenal 
tumors examined were microscopically confirmed to be adrenocortical adenomas. All 
patients signed a form of informed consent prepared in accordance with the rules 
outlined by the Nagasaki University Ethics Committee.  
  
In Situ Hybridization 
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cDNA fragments of StAR, CYP11A1, HSD3B2, CYP11B, CYP17A1, CYP21A2, 
SULT2A1 and MC2R, which were encoding human steroidogenic acute regulatory 
protein, cholesterol side-chain cleavage enzyme, 3β-hydroxysteroid dehydrogenase, 
11β-hydroxylase and/or aldosterone synthase, 17α-hydroxylase, 21-hydroxylase, 
dehydroepiandrosterone sulfotransferase and receptor for ACTH, respectively, were 
obtained by reverse transcriptase-polymerase chain reaction and subcloned into pT-NOT 
vector (11, 18). Antisense strand cRNAs were synthesized using Digoxigenin 
(DIG)-UTP (Roche Diagnostics, Tokyo, Japan) with T3 or T7 RNA polymerase (Takara, 
Otsu, Japan). The probe for CYP11B used in this study could not discriminate between 
11β-hydroxylase and aldosterone synthase, since the nucleotide sequences of CYP11B1 
and CYP11B2 encoding 11β-hydroxylase and aldosterone synthase are 95 % identical 
(11, 19). 
In situ hybridization was performed as described previously (11, 18). Briefly, 3 
μm-thick sections were hybridized with DIG-labeled cRNA probes at 420C for 16 hr, 
and finally washed in 0.2 x SCC at 500C for 20 min. Hybridization signals were 
immunologically detected with alkaline phosphatase-conjugated anti-DIG Fab 
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fragments (diluted 1:500; Roche Diagnostics). The specificity of the signals was 
examined using three negative-control procedures; (a) hybridization with sense cRNA 
probe, (b) pretreatment of tissue sections with RNase A, and (c) displacement by 




To discriminate between the expression of CYP11B1 and CYP11B2 mRNAs, we 
performed real-time PCR. Frozen adrenal glands attached to adrenocortical adenomas 
were cut into 7 μm-thick and consecutively 300 μm-thick sections in a cryostat. The 
former were used to examine the expression of HSD3B2 and CYP17A1 mRNAs by in 
situ hybridization, to determine the presence of subcapsular micronodules, and the latter 
were stored at -800C until RNA extraction. Under stereomicroscope, the tissues 
containing subcapsular micronodules were enucleated with a 400-μm needle (inside 
diameter) from frozen 300 μm-thick sections of adrenal glands. Total RNA was 
collected using GenElute Mammalian Total RNA kit (Sigma-Aldrich, Inc. MO). 
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Approximately 300 ng of total RNA was extracted from 10 enucleated tissues. The RT 
reaction proceeded at 420C for 60 min with 200 ng total RNA in a reaction mixture 
containing 50 ng random primer (Life Technologies, Grand Island, NY), 0.5 mM 
deoxy-NTPs, 10 mM dithiothreitol, 1 X reaction buffer, 50 U ribonuclease inhibitor 
(Takara, Otsu, Japan), and 100 U RT enzyme (Life Technologies) in a final volume of 
20 μl. The samples were heated at 950C for 10 min to inactivate RT activity and 
denature the RNA-cDNA hybrids. LightCycler Quick System 330 (Roche Diagnostic 
Co., Tokyo, Japan) was used for real-time PCR. Sequence-specific primers were 
designed, as previously described (20), and assigned the following GenBank accession 
numbers: CYP11B1 (X55764: 1435 – 1460 and 1534 - 1513), CYP11B2 (X54741: 2637 
– 2658 and 2724 - 2699). Expression levels were standardized by 18S rRNA (M10098: 
124 -148 and 256 – 232). All products were checked by electrophoresis using 3 % 
agarose gels and ethidium bromide staining with UV visualization to ensure the 
specificity of the PCR products and the absence of non-specific bands. Relative 
quantitation of gene expression was performed using the relative standard curve method. 
All real-time PCRs were done in triplicate. The sequence of PCR products was analyzed 
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using ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Tokyo, Japan), in 
accordance with the manufacturer's recommendations. The results were shown as mean




Expression of Steroidogenic Enzyme mRNAs in Control Adrenal Cortices 
  
Expression levels were heterogeneous within each adrenal cortex and differed among 
cases, but the site of expression of each mRNA was constant. StAR mRNA was found 
throughout the whole adrenal cortex, but not in the medulla (Fig. 1, A and B). CYP11A1 
and CYP17A1 mRNAs were expressed mainly in the zona fasciculata (ZF), followed by 
the zona reticularis (ZR) (Fig. 1, C and F). HSD3B2 mRNA was expressed in ZG and 
ZF, but only sporadically in ZR (Fig. 1, D). CYP11B and CYP21A2 mRNAs were 
intensely expressed in ZG and ZF, followed by ZR (Fig. 1 E and G). SULT2A1 mRNA 
expression was present mainly in ZR and extended to ZF (Fig. 1, H). MC2R mRNA was 
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expressed faintly in ZF and ZR (Fig. 1, I). In three cases, there were one or two 
microscopic subcapsular micronodules expressing StAR, CYP11A1, HSD3B2, CYP11B 
and CYP21A2, but not CYP17A1 (data not shown). These microscopic subcapsular 
micronodules were several to hundreds of micrometers in size and spheroid in shape. 
Cortical nodules in ZF to ZR expressing intensely for CYP17A1 mRNA were found in 
three cases, among which one expressed SULT2A1 mRNA (data not shown). There was 
no evidence of specific hybridization signals in the negative control (Fig. 1, J – L). 
 
Expression of Steroidogenic Enzyme mRNAs in the Adrenal Cortices Attached to APA 
 
The remaining cortices were of normal size and there was no suppression of 
expression for steroidogenic enzyme mRNAs (Fig. 2, A - F). SULT2A1 and MC2R 
mRNAs were expressed in ZF and ZR (Fig. 2, G and H) as in the control cortices. As 
expected, six cases (85.7 %) showed microscopic subcapsular micronodules suggesting 
aldosterone production, composed of spironolactone body-containing cells (Table 2; Fig. 
3, A – F). Cortical nodules with expression of StAR, CYP11A1, HSD3B2, CYP17A1, 
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CYP11B and CYP21A2 mRNAs, suggesting the capability for producing cortisol, were 
present in all cases (Table 2; Fig. 3, G – K). The majority of these nodules also 
co-expressed SULT2A1 and MC2R mRNAs (Table 2; Fig. 3, L).  
 
Expression of Steroidogenic Enzyme mRNAs in the Adrenal Cortices Attached to CPA 
 
The remaining cortices were atrophic, and consisted of mainly clear-type cells, in 
which the expression for steroidogenic enzymes was suppressed in general (Fig. 4). 
SULT2A1 mRNA was scattered throughout ZR and ZF cells. MC2R mRNA expression 
was also suppressed, but was present in a few cells of ZF and ZR (data not shown). 
Microscopic subcapsular micronodules (Table 2; Fig. 4) were noted in 15 cases 
(78.9 %). Most of the cortical nodules in ZF to ZR revealed a decreased expression for 
steroidogenic enzymes. However, 16 of 19 cases (84.2 %) contained cortical nodules 
expressing the mRNAs of steroidogenic enzymes necessary for production of cortisol 
(Table 2; Fig. 5, A – F). The composition of cells in some nodules showed pleomorphic 
nuclei and either eosinophilic or fine lipid-rich cytoplasm, as observed in primary 
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pigmented nodular adrenocortical disease (PPNAD). Of 16 cases, 9 cases had nodules 
that co-expressed SULT2A1 mRNA (Fig. 5, F) but not MC2R mRNA (Table 2). Only in 
case 22 did the nodule express both SULT2A1 and MC2R mRNAs (Table 2). Four cases 
of adrenal cortical hyperplasia with an unencapsulated extension into the periadrenal fat 
were composed of clear-type cells expressing HSD3B2 but not CYP17A1, and small 
compact-type cells expressing CYP17A1 but not HSD3B2 (Fig. 5, G and H). In 3 cases, 
pigmented cortical nodules were found, in which StAR, CYP11A1, CYP17A1 and 
SULT2A1 mRNAs were expressed, but not HSD3B2, CYP11B, CYP21A2 or MC2R 
mRNAs (data not shown).  
 
Expression of Steroidogenic Enzyme mRNAs in the Adrenal Cortices Attached to NFA 
 
Atrophic cortices were found in 7 of 11 cases. The expression of steroidogenic 
enzyme mRNAs was comparatively conserved. On the other hand, the suppressed 
expression of SULT2A1 and MC2R mRNAs was evident in the majority of cases.  
Microscopic subcapsular micronodules were found in 8 (72.7 %) of 11 cases (Table 2). 
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Cortical nodules expressing the mRNAs of steroidogenic enzymes necessary for 
production of cortisol were noted in 8 cases (72.7 %), but, among these, SULT2A1 or 




The tissues containing subcapsular micronodules expressing HSD3B2 but not 
CYP17A1 were examined (Fig. 6, A – C). As controls, APA tissues, and the capsular 
domain tissues without subcapsular micronodules were used. CYP11B1 and CYP11B2 
mRNAs were detectable in all tissues examined. Fig. 6D shows amplification curves for 
CYP11B1, CYP11B2 and 18S rRNA. Agarose gels produced by electrophoresis 
indicated the single bands for CYP11B1, CYP11B2 and 18S rRNA PCR products (Fig. 
6E), and the sequencing analysis demonstrated that the PCR products corresponded to 
CYP11B1 and CYP11B2 genes, respectively (data not shown). The ratio of 
CYP11B1/18S rRNA in the tissues containing subcapsular micronodules (2.44 x 10-3) 
was slightly elevated, when compared with that in APA tissues (n = 4; 1.56±0.09 x 
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10-3) and the capsular domain tissues without subcapsular micronodules (n = 3; 1.88±
0.09 x 10-3) (Fig. 7). On the other hand, the ratio of CYP11B2/18S rRNA in the tissues 
containing micronodules (1.81 x 10-4) was situated between the levels of APA tissues (n 
= 4; 3.84± 0.49 x 10-4) and the capsular domain tissues without subcapsular 




In this study, we examined the mRNA expression of steroidogenic enzymes in 
adrenal cortices attached to adrenocortical adenomas associated with PA and CA, as 
well as clinically silent cases, by in situ hybridization. The results in the control adrenal 
glands were similar to those of previous reports (11, 21 - 23). Additionally, the 
distribution of mRNA expression corresponded well with the zonal functions of the 
adrenal cortex (24), although detection of mRNA expression was not necessarily 
equivalent to the actual steroidogenic activity of tissues examined (25). The expression 
signals obtained in this study were specific and not false-positive, as demonstrated by 
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three negative-control studies. 
The remaining cortices in CPA were atrophic, reflecting the undetectable or very low 
levels of plasma ACTH resulting from the excessive neoplastic production of cortisol. 
The circulating ACTH concentrations also correlated well with the expression levels of 
SULT2A1 and MC2R mRNAs. In the atrophic cortices, the expression of SULT2A1 and 
MC2R mRNAs was suppressed, as described previously (23), while the cortices 
attached to APA were not atrophic and exhibited no suppression of either SULT2A1 or 
MC2R mRNAs. Atrophy was also observed in 7 of 11 cases assumed to be NFA. The 
past few years have seen an increase in the number of reports of adrenocortical adenoma 
associated with preclinical Cushing’s syndrome identified in cases previously regarded 
as NFA (26, 27). Cases 30, 32, 34, 36 and 37 showed low levels of plasma ACTH, loss 
of circadian rhythm or a significant isotope accumulation on an I131-aldosterol 
scintigram, providing the opportunity to correlate function with anatomic abnormalities 
(28). Hence, the possibility that at least these cases might actually be preclinical 
Cushing’s syndrome could not be ruled out, although the examinations necessary for 
this diagnosis were not adequate.   
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We demonstrated that some of the subcapsular micronodules intensely expressed the 
mRNAs of steroidogenic enzymes necessary for aldosterone production. Regardless of 
the size of the adenoma, subcapsular micronodules expressing StAR, CYP11A1, 
HSD3B2, CYP11B and CYP21A2, but not CYP17A1, were present in the cortices 
attached to APA at high frequency, as described previously (11). Unexpectedly, similar 
subcapsular micronodules were equally likely to be observed even in the controls and 
the cortices attached to CPA and NFA, although there were fewer subcapsular 
micronodules per case. As these micronodules were observed even in the controls 
showing no endocrine abnormalities, the possibility existed that the numbers of 
aldosterone-producing micronodules might be insufficient to provoke symptoms, or that 
the micronodules themselves might be unrelated to aldosterone production. However, 
subcapsular micronodules with the same morphology and expression pattern have been 
shown to be the main foci of aldosterone synthesis in some UAH cases (11). 
Additionally, the presence of spironolactone bodies in APA cases is proof that such 
microscopic subcapsular micronodules had enhanced steroidogenic activity, because 
spironolactone, a competitive antagonist of aldosterone receptors (29), directly 
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interferes with the overproduction of aldosterone through inhibition of 
11β-hydroxylation and 18-hydroxylation in human adrenal cortical tissue (30). These 
observations support the possibility that some of the subcapsular micronodules might be 
an initial focus for the later development into hyperplasia or adenoma, causing PA (11, 
31). By means of in situ hybridization, we could not confirm that excess aldosterone 
was actually synthesized in these micronodules, since the probe used for CYP11B could 
not distinguish 11β-hydroxylase from aldosterone synthase, being the enzyme for the 
final step of aldosterone synthesis. Enberg U et al. (31) have reported the expression of 
CYP11B2 mRNA in ZG by in situ hybridization using a radiolabeled oligonucleotide 
probe, and the autoradiogram exhibited seemed to indicate the presence of subcapsular 
micronodules expressing CYP11B2 mRNA. Hence, we performed real-time PCR to 
confirm the expression of CYP11B2 mRNA in the subcapsular micronodules. The level 
of CYP11B2 mRNA in the tissues containing micronodules was about 5.5-fold higher 
than that in the capsular domain tissues without micronodules, although the level of 
CYP11B2 mRNA was about 2-fold lower than that in APA tissues. These results 
indicate that, if not all, at least some subcapsular micronodules themselves expressed 
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levels of CYP11B2 mRNA sufficient for aldosterone production.  
In older individuals and in association with hypertension, there is an increased 
frequency of cortical nodules in ZF to ZR (8). Vascular sclerosing is a frequent finding 
in PA and CS. Cortical nodules are also frequently found in the cortices attached to APA, 
CPA and NFA (8). In this study, most of the nodules in ZF to ZR showed a decreased 
expression for steroidogenic enzymes. However, some were expressing all the necessary 
steroidogenic enzymes for cortisol production. We also demonstrated that adrenal 
cortical hyperplasia, with extension of cortical cells into the periadrenal fat, was 
composed of clear-type cells expressing HSD3B2 but not CYP17A1 and compact-type 
cells expressing CYP17A1 but not HSD3B2. Such differential expression of HSD3B2 
and CYP17A1 has been reported only in ACTH-independent macronodular 
adrenocortical hyperplasia (AIMAH) (32). Our results were consistent with those of 
previous reports showing the possibility that some nodules in the adrenal cortices of 
aging rats might be functional (9, 10). It is generally thought that cortical nodules occur 
as result of compensatory local tissue hyperplasia following ischemic damage (33). As 
is known, ACTH is an important factor to stimulate the growth of the adrenal cortex 
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through MC2R. Hence, we examined MC2R mRNA expression in the cortical nodules. 
MC2R mRNA was observed in the majority of APA cases, but absent in most of the 
CPA and NFA cases. Therefore, the nodules in the cortices of CPA or NFA were 
ACTH-independent, although those in the cortices attached to APA were considered to 
be still under ACTH regulation. At present, these nodules are generally thought to be 
mere distortions of the architecture of the cortex rather than clonal neoplastic growths, 
such as adenomas and carcinomas (33). Certainly, the relapse rate after adrenalectomy is 
extremely low. One possible explanation is that the function of most nodules indicated 
in this study may be episodic or transient. Another possibility is that a long time may be 
required for the nodules to develop sufficiently to cause endocrine disruption. Thirdly, 
the participation of factors other than ACTH may be required for symptoms to be 
produced. However, the possibility that some nodules in the cortices attached to 
adenoma may develop into autonomous lesions causing CS at a future point cannot be 
completely excluded, because relapse after even total adrenalectomy has been reported 
(3, 16), although rarely.  
Laparoscopic unilateral adrenalectomy is now the accepted method of surgery for 
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unilateral benign adrenal tumor, but the choice between total and subtotal 
adrenalectomy remains controversial (5, 7, 14, 17). Ishidoya S et al. (17) experienced 
cases in which hypertension with endocrinological abnormality remained after subtotal 
adrenalectomy, and, hence, warned about the risk of subtotal adrenalectomy. It is thus 
necessary to keep in mind that lesions with the potential to later develop into functional 
adrenocortical nodules may be present in the remaining adrenal cortices, if subtotal 
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Fig. 1. Expression of steroidogenic enzymes in the control. In the controls, StAR (B) 
mRNA was found throughout adrenal cortex. The expression of CYP11A1 (C) and 
CYP17A1 (F) mRNAs is found in ZF and ZR. HSD3B2 (D) mRNA is expressed in ZG 
and ZF, and sporadically expressed in ZR. CYP11B (E) and CYP21A2 (G) mRNAs are 
intensely expressed in ZG and ZF, followed by ZR. SULT2A1 (H) mRNA expression is 
present mainly in ZR and ZF. MC2R mRNA is expressed faintly in ZF and ZR (I). (J) – 
(L) show the negative controls; hybridization with StAR sense probe (J), pretreatment 
of tissue sections with RNase A before hybridization with StAR antisense probe (K), 
and displacement by addition of excess unlabeled StAR antisense probe (L). (A) stained 
with hematoxylin-eosin are consecutive sections of (B). med, medulla. 
 
Fig. 2. Expression of steroidogenic enzymes in the adrenal cortices attached to APA. 
The adrenal cortices attached to APA cells express steroidogenic enzymes including 
HSD3B2 (B), SULT2A1 (C) and MC2R (D) at the same level as the controls. (A) 
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stained with hematoxylin-eosin are consecutive sections of (B). 
 
Fig. 3. The expression of steroidogenic enzymes in the adrenal cortices attached to APA. 
Microscopic subcapsular micronodule with an intense expression of StAR (B), HSD3B2 
(C), CYP11B (D) and CYP21A2 (F), but not CYP17A1 (E: round dotted lines), can be 
seen. The majority of subcapsular micronodules in the adrenal cortices attached to APA 
are composed of spironolactone-body containing cells (A: arrow in square box). The 
cortical nodule in ZF to ZR expresses StAR (H), CYP11A1, HSD3B2 (I), CYP11B (J), 
CYP17A1 (K) and CYP21A2 mRNAs, suggesting the capability for cortisol production, 
and expression of MC2R (L) mRNA. (A) and (G) stained with hematoxylin-eosin are 
consecutive sections of (B) and (H), respectively. 
 
Fig. 4. Expression of steroidogenic enzymes in the adrenal cortex attached to CPA. In 
the adrenal cortices attached to CPA, the expression for steroidogenic enzymes is 
suppressed, but is comparatively conserved. In microscopic subcapsular micronodule, 
the expression of StAR (B), HSD3B2 (C), CYP11B (D) and CYP21A2 (F), but not 
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CYP17A1 (E: round dotted lines), can be seen. (A) stained with hematoxylin-eosin is 
consecutive sections of (B). 
 
Fig. 5. The expression of steroidogenic enzymes in the adrenal cortices attached to CPA. 
(A) to (F) indicate five cortical nodules (a – e) in the attached adrenal cortex. (a) and (c) 
show the expression of HSD3B2 (B), CYP11B (C) and CYP21A2 (E) mRNAs, but 
absent or sporadic expression of CYP17A1 (D) mRNA, suggesting the capability for 
aldosterone production. (b) and (d) show decreased expression of steroidogenic 
enzymes. (e) expresses all steroidogenic enzymes including SULT2A1 (F) mRNA, 
suggesting the capability for cortisol synthesis. The adrenal cortical hyperplasia with 
unencapsulated extension into the periadrenal fat is composed of cells expressing 
HSD3B2 (G) but not CYP17A1 (H) and the cells expressing CYP17A1 but not 
HSD3B2 (G and H: triangles). (A) stained with hematoxylin-eosin are consecutive 
sections of (B). med, medulla. 
 
Fig. 6. Analysis of CYP11B1 and CYP11B2 mRNA expression by real-time PCR. The 
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tissues containing a subcapsular micronodules expressing HSD3B2 (A) but not 
CYP17A1 (B, round dotted lines) are isolated. (C) is the section stained with toluidine 
blue after enucleation of the tissue containing subcapsular micronodule. (D) shows 
amplification curves for CYP11B1, CYP11B2 and 18S rRNA. (E) indicates the 
ethidium bromide staining of the 3 % agarose gels. Cap, the capsular domain tissues 
without subcapsular micronodules; M, the tissues containing subcapsular micronodule. 
 
Fig. 7. Ratios of CYP11B1/18S rRNA and CYP11B2/18S rRNA mRNAs. The results 
are shown as the ratio of CYP11B1 and CYP11B2 to 18S rRNA. A dotted line shows 
the mean value in APA tissues and the capsular domain tissues without micronodule, 
respectively. Student’s t test was used to compare APA tissues with the capsular domain 
tissues without subcapsular micronodules. Cap, the capsular domain tissues without 
subcapsular micronodules; M, the tissues containing subcapsular micronodule. 
































Clin, clinical diagnosis; PA, primary aldosteronism; CS, Cushing’s syndrome; NF, 
clinical silent; BP, blood pressure (mmHg); Ald, plasma aldosterone (29.9 ~159 pg/ml, 
*35.7～240 pg/ml), F, plasma cortisol (6.2 ~ 19.4 μg/ml); Renin, plasma renin (2.5 ~ 
21.4 pg/ml); 17, 17-OHCS (2.2 ~ 7.3 mg/day); ACTH, plasma ACTH (7 ~56 pg/ml), 
CR, circadian rhythm: Dex, dexamethasone suppression test; Sca, isotope accumulation 
on an I131-aldosterol scintigram; Drug, ant-hypertensive agents, A (spironolactone), B 






























































































































































































































































































































































































































































































































































a, nodules suggesting the capability for producing aldosterone; b, nodules expressing an 
intense CYP17A1 but not SULT2A1; c, nodules co-expressing SULT2A1; d, nodules 
co-expressing MC2R; e, nodules with decreased expression for steroidogenic enzymes; 
Diag, pathological diagnosis; APA, aldosterone-producing adenoma; CPA, 
cortisol-producing adenoma; NFA, nonfunctioning adenoma; “Atrophy” indicates the 
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